Spark Therapeutics unites the brightest minds in gene
therapy, establishing world-class, end-to-end, integrated
capabilities to discover, develop and deliver life-changing
treatments. Our fully integrated, commercial company is
headquartered in Philadelphia’s University City, and our
work includes a focus on ocular, systemic and neuroscience
therapeutic areas. As a member of the Roche Group, we
operate autonomously while benefitting from the strategic
investment and intellectual collaboration of a global
company. We are a proven leader in the life sciences
industry, and successfully navigated the delivery of the first
FDA-approved gene therapy for a genetic disease.
